查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945402

2026年全球介入性肿瘤消融市场报告

Interventional Tumor Ablation Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，介入性肿瘤消融市场发展迅速，预计将从2025年的17.7亿美元成长到2026年的19.3亿美元，复合年增长率达8.5%。过去几年的成长可归因于全球癌症发生率的上升、医学影像技术的进步、微创疗法日益受到青睐、介入性肿瘤学实践的扩展以及消融手术临床疗效的改善。

预计未来几年介入性肿瘤消融市场规模将维持强劲成长，2030年将达到26.6亿美元，复合年增长率（CAGR）为8.5%。预测期内的成长要素包括人工智慧辅助影像引导技术的日益普及、个人化癌症治疗的广泛应用、门诊手术中心的扩张、肿瘤设备创新投资的增加以及对经济高效癌症治疗方法日益增长的需求。预测期内的主要趋势包括微创肿瘤消融手术的日益普及、影像引导消融技术的日益广泛应用、微波和射频消融术系统的扩展、对门诊癌症治疗需求的增长以及对精准肿瘤学的日益重视。

预计未来几年，癌症发生率的不断上升将推动介入性肿瘤消融市场的成长。癌症是一组疾病，其特征是异常细胞不受控制地生长和扩散，这些细胞可以侵入周围组织，并透过血液和淋巴系统转移到身体的其他部位。癌症发生率的上升主要归因于生活方式和环境因素，例如吸烟、不健康饮食、肥胖以及接触致癌性。介入性肿瘤消融术透过提供一种微创的治疗方法传统手术的方案来辅助癌症治疗。这些技术能够精准地摧毁肿瘤，缩短治疗和恢復时间，并改善患者的预后和生活品质。例如，根据联合国专门机构世界卫生组织（世卫组织）的数据，截至2024年2月，预计到2025年，全球新增癌症病例将超过3,500万例，比2022年估计的2,000万例增加77%。因此，癌症发生率的上升正在推动介入性肿瘤消融市场的扩张。

为了提高手术精准度并改善治疗效果，介入性肿瘤消融市场的主要企业正致力于开发先进的技术解决方案，例如BioTrace软体套件。 BioTrace软体套件是一个整合平台，旨在追踪、管理和分析生物学和临床数据，尤其适用于医疗和研究环境。例如，2024年7月，总部位于以色列的医疗设备製造商TechsoMed Medical Technologies Ltd.宣布推出BioTraceIO Vision和BioTraceIO Precision，这两款软体解决方案专为影像导引的肝肿瘤消融治疗而开发。 BioTraceIO Vision利用基于标准医学影像的人工智慧驱动的个人化治疗计画和评估工具，以提高肝肿瘤​​消融的精确度和效率。同时，BioTraceIO Precision可在手术过程中和术后提供基于超音波的消融区域即时可视化和预测性映射。这使得临床医生能够评估组织损伤和治疗效果，并且已被证明与消融后24小时的电脑断层扫描结果高度相关。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球介入性肿瘤消融市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 自主系统、机器人与智慧运输
  • 主要趋势
    • 微创肿瘤消融手术的应用日益增多
    • 影像导引消融技术的应用日益广泛
    • 扩展微波和射频消融术系统
    • 门诊癌症治疗的需求不断增长
    • 日益关注精准肿瘤学

第五章 终端用户产业市场分析

  • 医院
  • 癌症治疗中心
  • 门诊手术中心
  • 研究所
  • 专科诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球介入性肿瘤消融市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球介入性肿瘤消融市场规模、对比及成长率分析
  • 全球介入性肿瘤消融市场表现：规模与成长，2020-2025年
  • 全球介入性肿瘤消融市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依手术类型
  • 微创手术，影像导引治疗
  • 透过技术
  • 射频消融术（RFA）、微波消融术（MWA）、冷冻疗法、雷射消融术、高强度聚焦超音波（HIFU）
  • 依设备类型
  • 消融系统、耗材、辅助设备、诊断影像系统
  • 按应用程式字段
  • 肝臟肿瘤、肾臟肿瘤、肺部肿瘤、骨骼肿瘤
  • 最终用户
  • 医院、专科癌症治疗中心、门诊手术中心及研究机构
  • 按类型细分：微创手术
  • 经皮肿瘤消融术、内视镜消融术
  • 按类型细分：影像导引治疗
  • CT引导肿瘤消融术、MRI引导肿瘤消融术、超音波引导肿瘤消融术

第十章 区域与国家分析

  • 全球介入性肿瘤消融市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球介入性肿瘤消融市场：依国家划分、绩效及预测（2020-2025年、2025-2030年预测、2035年预测）

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 介入性肿瘤消融市场：竞争格局及市场占有率（2024年）
  • 介入性肿瘤消融市场：公司估值矩阵
  • 介入性肿瘤消融市场：公司概况
    • Johnson & Johnson
    • Medtronic plc
    • Siemens Healthineers AG
    • Stryker Corporation
    • Boston Scientific Corporation

第37章：其他领先和创新企业

  • Olympus Corporation, Terumo Corporation, EDAP TMS SA, Elekta AB, AngioDynamics Inc., InSightec Ltd., Cascination AG, IceCure Medical Ltd., Theraclion SA, Mermaid Medical Group A/S, HS Hospital Service SpA, Varian Medical Systems Inc., Neuwave Medical, BTG plc, MedWaves Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年介入性肿瘤消融市场：提供新机会的国家
  • 2030年介入性肿瘤消融市场：充满新机会的细分市场
  • 2030年介入性肿瘤消融市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MITAU01_G26Q1

Interventional tumor ablation is a minimally invasive procedure that utilizes image-guided techniques to target and destroy cancerous or benign tumors without the need for open surgery. It uses thermal or non-thermal energy to eliminate tumor cells while minimizing damage to surrounding healthy tissue. This procedure is often employed when surgery is not viable or as an alternative to traditional treatments.

The main product types in interventional tumor ablation include open surgery, minimally invasive surgery, and image-guided interventions. Open surgery involves making an incision in the body to access and treat the affected area, typically using scalpels and other instruments. Key technologies in this field include radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, laser ablation, and high-intensity focused ultrasound (HIFU). Device types used in these procedures include ablation systems, consumables, support devices, and imaging systems. Tumor ablation is frequently applied to liver, kidney, lung, and bone tumors. The end users of these technologies range from hospitals and specialized cancer treatment centers to ambulatory surgical centers and research institutes.

Tariffs are influencing the interventional tumor ablation market by increasing costs of imported ablation probes, imaging systems, electronic control units, and specialized medical components used in rfa, mwa, cryoablation, and hifu systems. Hospitals and cancer centers in North America and Europe are most affected due to reliance on imported high-end medical devices, while Asia-Pacific faces cost pressure on device exports. These tariffs are increasing capital expenditure and slowing equipment replacement cycles. However, they are also encouraging local manufacturing, regional device assembly, and innovation in cost-optimized ablation technologies.

The interventional tumor ablation market research report is one of a series of new reports from The Business Research Company that provides interventional tumor ablation market statistics, including interventional tumor ablation industry global market size, regional shares, competitors with a interventional tumor ablation market share, detailed interventional tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the interventional tumor ablation industry. This interventional tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional tumor ablation market size has grown strongly in recent years. It will grow from $1.77 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising global cancer incidence, advancement of medical imaging technologies, increasing preference for minimally invasive therapies, expansion of interventional oncology practices, improved clinical outcomes of ablation procedures.

The interventional tumor ablation market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing integration of ai-assisted imaging guidance, rising adoption of personalized cancer treatment, expansion of ambulatory surgical centers, growing investments in oncology device innovation, increasing demand for cost-effective cancer therapies. Major trends in the forecast period include increasing adoption of minimally invasive tumor ablation procedures, rising use of image-guided ablation technologies, expansion of microwave and radiofrequency ablation systems, growing demand for outpatient cancer treatments, enhanced focus on precision oncology.

The increasing incidence of cancer is expected to drive the growth of the interventional tumor ablation market in the coming years. Cancer encompasses a group of diseases marked by the uncontrolled growth and spread of abnormal cells, which can invade surrounding tissues and spread to other parts of the body through the blood and lymphatic systems. The rising occurrence of cancer is largely attributed to lifestyle and environmental factors, including smoking, unhealthy diets, obesity, and exposure to carcinogenic substances. Interventional tumor ablation supports cancer treatment by providing minimally invasive therapeutic options that serve as alternatives to conventional surgery. These techniques shorten treatment durations and recovery times by enabling precise tumor destruction, thereby improving patient outcomes and quality of life. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, more than 35 million new cancer cases are projected globally by 2025, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising incidence of cancer is contributing to the expansion of the interventional tumor ablation market.

Leading companies operating in the interventional tumor ablation market are concentrating on the development of advanced technological solutions, such as BioTrace software suites, to improve procedural accuracy and enhance treatment effectiveness. BioTrace software suites are integrated platforms designed to track, manage, and analyze biological and clinical data, particularly within healthcare and research settings. For example, in July 2024, TechsoMed Medical Technologies Ltd., an Israel-based medical device manufacturer, introduced BioTraceIO Vision and BioTraceIO Precision, software solutions developed for image-guided liver tumor ablation therapy. BioTraceIO Vision utilizes artificial intelligence-driven personalized treatment planning and assessment tools based on standard medical imaging to increase the precision and efficiency of liver tumor ablation. BioTraceIO Precision offers real-time ultrasound-based visualization and predictive mapping of the ablation zone during and after procedures, enabling clinicians to evaluate tissue damage and treatment outcomes with strong correlation to 24-hour post-ablation computed tomography scans.

In February 2024, Immunophotonics Inc., a US-based biotechnology company, entered into a partnership with AngioDynamics Inc. This collaboration is intended to combine Immunophotonics' lead immunotherapy candidate, IP-001, with AngioDynamics' ablation technologies to investigate the potential of integrating ablation with immunotherapy for the treatment of solid tumor cancers. AngioDynamics Inc. is a US-based medical device company that provides microwave and radiofrequency ablation systems for minimally invasive cancer therapies.

Major companies operating in the interventional tumor ablation market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, EDAP TMS S.A., Elekta AB, AngioDynamics Inc., InSightec Ltd., Cascination AG, IceCure Medical Ltd., Theraclion SA, Mermaid Medical Group A/S, H.S. Hospital Service S.p.A., Varian Medical Systems Inc., Neuwave Medical, BTG plc, MedWaves Inc., Perseon Medical AB, Chongqing Haifu Medical Technology Co. Ltd., AngioDynamics Nanoknife Division, Galil Medical Inc.

North America was the largest region in the interventional tumor ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional tumor ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the interventional tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The interventional tumor ablation market consists of revenues earned by entities by providing services such as electroporation, tumor biopsy services, thermal ablation monitoring, and post-ablation follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional tumor ablation market also includes sales of radiofrequency ablation (RFA) generators, microwave ablation (MWA) systems, cryoablation probes, laser fibers and electrode needles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Tumor Ablation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses interventional tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional tumor ablation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Procedure Type: Minimally Invasive Surgery; Image-Guided Interventions
  • 2) By Technology: Radiofrequency Ablation (RFA); Microwave Ablation (MWA); Cryoablation; Laser Ablation; High-Intensity Focused Ultrasound (HIFU)
  • 3) By Device Type: Ablation Systems; Consumables; Support Devices; Imaging Systems
  • 4) By Application Area: Liver Tumors; Kidney Tumors; Lung Tumors; Bone Tumors
  • 5) By End User: Hospitals; Specialized Cancer Treatment Centers; Ambulatory Surgical Centers; Research Institutes
  • Subsegments:
  • 1) By Minimally Invasive Surgery: Percutaneous Tumor Ablation; Endoscopic Ablation
  • 2) By Image-Guided Interventions: Computed Tomography-Guided Tumor Ablation; Magnetic Resonance Imaging-Guided Tumor Ablation; Ultrasound-Guided Tumor Ablation
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; Terumo Corporation; EDAP TMS S.A.; Elekta AB; AngioDynamics Inc.; InSightec Ltd.; Cascination AG; IceCure Medical Ltd.; Theraclion SA; Mermaid Medical Group A/S; H.S. Hospital Service S.p.A.; Varian Medical Systems Inc.; Neuwave Medical; BTG plc; MedWaves Inc.; Perseon Medical AB; Chongqing Haifu Medical Technology Co. Ltd.; AngioDynamics Nanoknife Division; Galil Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Interventional Tumor Ablation Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Interventional Tumor Ablation Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Interventional Tumor Ablation Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Interventional Tumor Ablation Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Tumor Ablation Procedures
    • 4.2.2 Rising Use Of Image-Guided Ablation Technologies
    • 4.2.3 Expansion Of Microwave And Radiofrequency Ablation Systems
    • 4.2.4 Growing Demand For Outpatient Cancer Treatments
    • 4.2.5 Enhanced Focus On Precision Oncology

5. Interventional Tumor Ablation Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cancer Treatment Centers
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Research Institutes
  • 5.5 Specialty Clinics

6. Interventional Tumor Ablation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Interventional Tumor Ablation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Interventional Tumor Ablation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Interventional Tumor Ablation Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Interventional Tumor Ablation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Interventional Tumor Ablation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Interventional Tumor Ablation Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Interventional Tumor Ablation Market Segmentation

  • 9.1. Global Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Minimally Invasive Surgery, Image-Guided Interventions
  • 9.2. Global Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)
  • 9.3. Global Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ablation Systems, Consumables, Support Devices, Imaging Systems
  • 9.4. Global Interventional Tumor Ablation Market, Segmentation By Application Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liver Tumors, Kidney Tumors, Lung Tumors, Bone Tumors
  • 9.5. Global Interventional Tumor Ablation Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialized Cancer Treatment Centers, Ambulatory Surgical Centers, Research Institutes
  • 9.6. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Minimally Invasive Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Percutaneous Tumor Ablation, Endoscopic Ablation
  • 9.7. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Image-Guided Interventions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Computed Tomography-Guided Tumor Ablation, Magnetic Resonance Imaging-Guided Tumor Ablation, Ultrasound-Guided Tumor Ablation

10. Interventional Tumor Ablation Market Regional And Country Analysis

  • 10.1. Global Interventional Tumor Ablation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Interventional Tumor Ablation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Interventional Tumor Ablation Market

  • 11.1. Asia-Pacific Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Interventional Tumor Ablation Market

  • 12.1. China Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Interventional Tumor Ablation Market

  • 13.1. India Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Interventional Tumor Ablation Market

  • 14.1. Japan Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Interventional Tumor Ablation Market

  • 15.1. Australia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Interventional Tumor Ablation Market

  • 16.1. Indonesia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Interventional Tumor Ablation Market

  • 17.1. South Korea Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Interventional Tumor Ablation Market

  • 18.1. Taiwan Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Interventional Tumor Ablation Market

  • 19.1. South East Asia Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Interventional Tumor Ablation Market

  • 20.1. Western Europe Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Interventional Tumor Ablation Market

  • 21.1. UK Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Interventional Tumor Ablation Market

  • 22.1. Germany Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Interventional Tumor Ablation Market

  • 23.1. France Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Interventional Tumor Ablation Market

  • 24.1. Italy Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Interventional Tumor Ablation Market

  • 25.1. Spain Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Interventional Tumor Ablation Market

  • 26.1. Eastern Europe Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Interventional Tumor Ablation Market

  • 27.1. Russia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Interventional Tumor Ablation Market

  • 28.1. North America Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Interventional Tumor Ablation Market

  • 29.1. USA Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Interventional Tumor Ablation Market

  • 30.1. Canada Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Interventional Tumor Ablation Market

  • 31.1. South America Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Interventional Tumor Ablation Market

  • 32.1. Brazil Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Interventional Tumor Ablation Market

  • 33.1. Middle East Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Interventional Tumor Ablation Market

  • 34.1. Africa Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Interventional Tumor Ablation Market Regulatory and Investment Landscape

36. Interventional Tumor Ablation Market Competitive Landscape And Company Profiles

  • 36.1. Interventional Tumor Ablation Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Interventional Tumor Ablation Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Interventional Tumor Ablation Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Interventional Tumor Ablation Market Other Major And Innovative Companies

  • Olympus Corporation, Terumo Corporation, EDAP TMS S.A., Elekta AB, AngioDynamics Inc., InSightec Ltd., Cascination AG, IceCure Medical Ltd., Theraclion SA, Mermaid Medical Group A/S, H.S. Hospital Service S.p.A., Varian Medical Systems Inc., Neuwave Medical, BTG plc, MedWaves Inc.

38. Global Interventional Tumor Ablation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Interventional Tumor Ablation Market

40. Interventional Tumor Ablation Market High Potential Countries, Segments and Strategies

  • 40.1 Interventional Tumor Ablation Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Interventional Tumor Ablation Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Interventional Tumor Ablation Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer